Binding of ISRIB reveals a regulatory site in the nucleotide exchange factor eIF2B
Author(s) -
Alisa Zyryanova,
Félix Weis,
Alexandre Faille,
Akeel Abo Alard,
Ana Crespillo-Casado,
Yusuke Sekine,
Heather P. Harding,
Felicity Allen,
Leopold Parts,
Christophe Fromont,
Peter M. Fischer,
Alan J. Warren,
David Ron
Publication year - 2018
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.aar5129
Subject(s) - a site , translation (biology) , binding site , biology , biophysics , microbiology and biotechnology , chemistry , computational biology , biochemistry , gene , messenger rna
ISRIB mechanism of action In rodents, a druglike small molecule named ISRIB enhances cognition and reverses cognitive deficits after traumatic brain injury. ISRIB activates a protein complex called eIF2B that is required for the synthesis of new proteins. Tsaiet al. report the visualization of eIF2B bound to ISRIB at near-atomic resolution by cryo–electron microscopy. Biochemical studies revealed that ISRIB is a “molecular staple” that promotes assembly of the fully active form of eIF2B. Zyryanovaet al. report similar structures together with information on the binding of ISRIB analogs and their effects on protein translation.Science , this issue p.eaaq0939 , p.1533
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom